Most Recent
Labour on-hire and recruitment company CoreStaff is facing a class action alleging it violated the consumer laws by luring workers to Australia from Papua New Guinea with the promise of long-term work, only to terminate their employment agreements less than three years after they relocated.
The judge overseeing the complex liquidation of failed auction house Mossgreen has denied leave to proceed to vendors who received nothing from the sale of their art collections.
Hotel booking aggregator Trivago has admitted it may have misled consumers into believing they would find the lowest hotel rate on an initial search of its site and that it had breached the Australian Consumer Law.
E-retailer Catch Group has filed a trade mark lawsuit against a popular online classified ads provider over its "Catch of the week" and "Catch of the month" promotions.
The companies that own some of Australia's largest intellectual property boutiques have agreed to a merger that will create a 349 employee-strong firm that's a force to be reckoned with in the market for IP services in Asia Pacific.
Surgical mesh devices, including the controversial urogynaecological mesh devices that are at the centre of two high-stakes class actions, will soon face a higher bar for regulatory approval.
US television giant Bravo can't trade mark the phrase "Just Desserts" in Australia for its Top Chef reality cooking show spinoff, a sweet victory for the Seven Network, which challenged the mark.
A unit of Nestle unit has defeated an opposition to a patent for an internet-connected coffee machine that would allow users to read news and weather while making their morning coffee.
A judge has taken a hatchet to Quinn Emanuel's fees and the funder's cut in a $12 million settlement of a class action against Bank of Queensland, a settlement which he previously described as one of the "worst" he'd ever seen.
GlaxoSmithKline has won approval for a patent for a vaccine to prevent a common respiratory virus affecting infants, beating out a challenge from a rival that has developed a competing vaccine.